Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma
Por um escritor misterioso
Descrição
Frontiers How to Choose the Correct Drug in Severe Pediatric Asthma
A study participated by Vall d'Hebron made possible the
Dupixent (dupilumab) for the Treatment of Atopic Dermatitis, US
Dupilumab Improves Clinical Scores in Children and Adolescents
Discoveries in Medicine - Study Approves Dupilumab Option for
JCM, Free Full-Text
New monoclonal antibody shows promise for severe asthma
Efficacy of dupilumab in asthma.
Full article: Dupilumab in the management of moderate-to-severe
Dupilumab reduces attacks and improves lung function in asthmatic
Biomedicines, Free Full-Text
Sanofi, Regeneron Report Positive Phase 3 Results For Asthma Drug
Dupilumab leads to better-controlled asthma and quality of life in
de
por adulto (o preço varia de acordo com o tamanho do grupo)
